Clinical Trial Update: Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining how serotonin transporter genetic variation influences amygdala responses to antidepressants in major depressive disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Antidepressants

Snippet

Sponsor: University of Calgary | Conditions: Major Depressive Disorder | Phase 4 | Status: COMPLETED